Active	Status	Sponsor type	Region	Phase	Filter
3 Active 5 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Veldhuizen, Peter J Van
NCT03977467: Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor	Active, not recruiting	2	80	US	Atezolizumab, TECENTRIQ, Chemotherapy (Arm A Only), Tiragolumab	SCRI Development Innovations, LLC, Genentech, Inc.	Non-Small Cell Lung Cancer, Solid Tumor	07/24	07/24
NCT04731844: Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer	Recruiting	2	40	US	Curcumin plus Piperine, Curcumin C3 Complex®	University of Rochester	Prostate Cancer, Multiple Myeloma, Smoldering Multiple Myeloma (SMM), Monoclonal Gammopathy of Undetermined Significance	05/24	05/24
Feeback, Jennifer
PROGECT, NCT02302742: Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry	Recruiting	N/A	1500	US		University of Kansas Medical Center	Breast Cancer, Hereditary Breast and Ovarian Cancer	12/24	12/25
Altman, Christy
No trials found